HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS

    公开(公告)号:US20210292435A1

    公开(公告)日:2021-09-23

    申请号:US17083163

    申请日:2020-10-28

    Abstract: The present application discloses high-concentration monoclonal antibody formulations suitable for subcutaneous administration, e.g. via a pre-filled syringe. In particular, it discloses a formulation comprising a spray dried monoclonal antibody at a concentration of about 200 mg/mL or more suspended in a non-aqueous suspension vehicle where the viscosity of the suspension vehicle is less than about 20 centipoise. Also disclosed are: a subcutaneous administration device with the formulation therein, a method of making the formulation, a method of making an article of manufacture comprising the suspension formulation, use of the formulation in the preparation of a medicament, and a method of treating a patient with the formulation.

    HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS

    公开(公告)号:US20240425615A1

    公开(公告)日:2024-12-26

    申请号:US18673164

    申请日:2024-05-23

    Abstract: The present application discloses high-concentration monoclonal antibody formulations suitable for subcutaneous administration, e.g. via a pre-filled syringe. In particular, it discloses a formulation comprising a spray dried monoclonal antibody at a concentration of about 200 mg/mL or more suspended in a non-aqueous suspension vehicle where the viscocity of the suspension vehicle is less than about 20 centipoise. Also disclosed are: a subcutaneous administration device with the formulation therein, a method of making the formulation, a method of making an article of manufacture comprising the suspension formulation, use of the formulation in the preparation of a medicament, and a method of treating a patient with the formulation.

    HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
    3.
    发明申请
    HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS 审中-公开
    高浓度单克隆抗体制剂

    公开(公告)号:US20160176986A1

    公开(公告)日:2016-06-23

    申请号:US14752670

    申请日:2015-06-26

    Abstract: The present application discloses high-concentration monoclonal antibody formulations suitable for subcutaneous administration, e.g. via a pre-filled syringe. In particular, it discloses a formulation comprising a spray dried monoclonal antibody at a concentration of about 200 mg/mL or more suspended in a non-aqueous suspension vehicle where the viscocity of the suspension vehicle is less than about 20 centipoise. Also disclosed are: a subcutaneous administration device with the formulation therein, a method of making the formulation, a method of making an article of manufacture comprising the suspension formulation, use of the formulation in the preparation of a medicament, and a method of treating a patient with the formulation.

    Abstract translation: 本申请公开了适用于皮下给药的高浓度单克隆抗体制剂,例如, 通过预先填充的注射器。 特别地,其公开了一种制剂,其包含浓度为约200mg / mL或更高的喷雾干燥的单克隆抗体,其悬浮于非水悬浮液中,其中悬浮载体的粘度小于约20厘泊。 还公开了:其中具有制剂的皮下给药装置,制备制剂的方法,制备包含悬浮液制剂的制品的方法,制剂在制备药物中的用途,以及治疗方法 患者配方。

Patent Agency Ranking